Balchem Corporation to Participate in the BNP Paribas Exane Consumer Ingredients & Chemicals Conference on March 11, 2026

Rhea-AI Summary

Balchem (NASDAQ: BCPC) will participate in the BNP Paribas Exane Consumer Ingredients & Chemicals Conference on March 11, 2026. Company executives Ted Harris (Chairman, President & CEO), Martin Bengtsson (CFO) and Allison Baurichter (Senior Director Investor Relations) will attend and speak.

Key Figures

Conference date: March 11, 2026

1 metrics

Conference date March 11, 2026 BNP Paribas Exane Consumer Ingredients & Chemicals Conference

Market Reality Check

Price: $178.56 Vol: Volume 197,127 is at 1.14...

normal vol

$178.56 Last Close

Volume Volume 197,127 is at 1.14x the 20-day average of 172,552 ahead of the conference update. normal

Technical Shares at $178.56 trade above the 200-day MA of $159.17, sitting 2.43% below the 52-week high of $183.01 and 28.3% above the 52-week low of $139.17.

Peers on Argus

BCPC gained 1.64% while only one peer in the momentum scan, SSL, showed movement...

1 Down

BCPC gained 1.64% while only one peer in the momentum scan, SSL, showed movement, declining 1.3500000350177288% without same-day news, suggesting a stock-specific move rather than a broad specialty chemicals rotation.

Historical Context

5 past events · Latest: Feb 20 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 20	Earnings release	Positive	-3.6%	Record 2025 sales, earnings and free cash flow with higher dividend.
Feb 06	Earnings call notice	Neutral	-0.3%	Scheduled Q4 and full-year 2025 results conference call details.
Jan 02	Investor conference	Neutral	+0.4%	Participation in CJS virtual conference to discuss strategy with investors.
Dec 22	Regulatory trade action	Positive	+0.5%	EU anti-dumping duties on Chinese choline chloride imports for five years.
Dec 10	Dividend increase	Positive	+2.4%	Annual dividend of $0.96 per share, up 10.3%, seventeenth straight increase.

Pattern Detected

BCPC’s news flow has generally seen price moves align with positive developments, except for a recent strong earnings report that coincided with a short-term decline.

Recent Company History

This announcement adds another investor-focused event to a steady stream of recent corporate updates. On Feb 20, 2026, Balchem reported record $1.037 billion 2025 net sales and record adjusted EBITDA of $274.9 million, yet shares fell 3.6%. Prior items included the Feb 20 earnings call notice, January and February conference appearances, supportive EU anti-dumping duties on choline chloride published Dec 19, 2025, and a $0.96 dividend with a 10.3% increase, which drew a positive market reaction.

Market Pulse Summary

This announcement highlights continued engagement with the investment community as Balchem’s leaders...

Analysis

This announcement highlights continued engagement with the investment community as Balchem’s leadership participates in a March 11, 2026 industry conference. It follows record 2025 financial performance, a 10.3% dividend increase to $0.96 per share, and supportive EU trade measures on choline chloride. Investors may watch how management commentary at the event reinforces recent earnings trends, capital allocation priorities, and end-market demand across its Human Nutrition, Animal Nutrition, and Specialty Products segments.

AI-generated analysis. Not financial advice.

MONTVALE, N.J., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the BNP Paribas Exane Consumer Ingredients & Chemicals Conference on March 11, 2026. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will participate in the conference.

About Balchem Corporation

Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.

Contact:         Jacqueline Yarmolowicz
                       Balchem Corporation (Telephone: 845-326-5600)

FAQ

When will Balchem (BCPC) present at the BNP Paribas Exane Consumer Ingredients & Chemicals Conference?

Balchem will participate on March 11, 2026 with company representatives attending. According to the company, Ted Harris, Martin Bengtsson and Allison Baurichter will represent Balchem at the conference to engage with investors and industry attendees.

Who will represent Balchem (BCPC) at the March 11, 2026 conference?

Balchem's delegation includes Ted Harris, Martin Bengtsson, and Allison Baurichter. According to the company, Harris is chairman, president and CEO; Bengtsson is CFO; Baurichter is senior director of investor relations.

Where can investors access Balchem (BCPC) conference materials or presentation on March 11, 2026?

Investors should check Balchem's investor relations resources for access to materials and a webcast. According to the company, investor relations is the appropriate channel for slides, replay links, or post‑conference materials following the event.

What is the purpose of Balchem (BCPC) attending the BNP Paribas Exane conference on March 11, 2026?

Balchem will attend to engage with investors and discuss company developments and strategy. According to the company, executive participation aims to provide investor updates and respond to questions from analysts and institutional attendees at the conference.

How can analysts prepare questions for Balchem (BCPC) at the March 11, 2026 conference?

Analysts should compile targeted questions on operations, financials, and strategy ahead of the event. According to the company, investor relations will coordinate engagement and can provide logistics for one‑on‑one or panel interactions during the conference.